Amicus Therapeutics
FOLD
$10.28
Share price
1.08%
Change (1 day)
-10.92%
Change (1 year)
Categories
Amicus Therapeutics (FOLD) - Net assets
Net assets on the balance sheet as of December 2023 : $0.16 B
According to Amicus Therapeutics
's latest financial reports the company has $0.16 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Amicus Therapeutics - Net assets on balance sheet (from 2005 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.16 B | 30.17% |
| 2022-12-31 | $0.12 B | -59.97% |
| 2021-12-31 | $0.30 B | 7.33% |
| 2020-12-31 | $0.28 B | -39.89% |
| 2019-12-31 | $0.47 B | 38.94% |
| 2018-12-31 | $0.34 B | -2.82% |
| 2017-12-31 | $0.35 B | -2.03% |
| 2016-12-31 | $0.36 B | 3.54% |
| 2015-12-31 | $0.34 B | 184.69% |
| 2014-12-31 | $0.12 B | 167.05% |
| 2013-12-31 | $45.75 M | -33.9% |
| 2012-12-31 | $69.22 M | 133.91% |
| 2011-12-31 | $29.59 M | -54.43% |
| 2010-12-31 | $64.93 M | -9.6% |
| 2009-12-31 | $71.83 M | 1.11% |
| 2008-12-31 | $71.04 M | -31.22% |
| 2007-12-31 | $0.10 B | -233.26% |
| 2006-12-31 | $-77.52 M | 116.34% |
| 2005-12-31 | $-35.83 M | |
| 2003-12-31 | $-5.28 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Novo Nordisk NVO | $15.78 B | 9,753.03% | 🇩🇰 Denmark |
 Biogen BIIB | $15.21 B | 9,397.80% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $16.28 B | 10,068.94% | 🇬🇧 UK |
 Lexicon Pharmaceuticals
LXRX | $93.11 M | -41.87% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | -$0.46 B | -384.06% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $4.95 B | 2,991.36% | 🇺🇸 USA |